Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
The members of the Italian Integrated Surveillance of COVID-19 study group are acknowledged at the end of the article.
Euro Surveill. 2021 Nov;26(47). doi: 10.2807/1560-7917.ES.2021.26.47.2101001.
We assessed the impact of COVID-19 vaccination in Italy, by estimating numbers of averted COVID-19 cases, hospitalisations, ICU admissions and deaths between January and September 2021, by age group and geographical macro areas. Timing and speed of vaccination programme implementation varied slightly between geographical areas, particularly for older adults. We estimated that 445,193 (17% of expected; range: 331,059-616,054) cases, 79,152 (32%; range: 53,209-148,756) hospitalisations, 9,839 ICU admissions (29%; range: 6,434-16,276) and 22,067 (38%; range: 13,571-48,026) deaths were prevented by vaccination.
我们评估了 COVID-19 疫苗接种在意大利的影响,通过估计 2021 年 1 月至 9 月期间按年龄组和地理大区划分的避免 COVID-19 病例、住院、重症监护病房(ICU)入院和死亡的人数。疫苗接种计划的实施时间和速度在地理区域之间略有差异,特别是对于老年人而言。我们估计,疫苗接种预防了 445193 例(预期的 17%;范围:331059-616054)病例、79152 例(32%;范围:53209-148756)住院、9839 例(29%;范围:6434-16276)ICU 入院和 22067 例(38%;范围:13571-48026)死亡。